Urgell, AC, Garcia, O, Pena, E, Vilahur, G, Marques, GA. Long-term tissue factor expression orchestrates the angiogenic potential of adipose derived stem cells through par smad signaling and activin a cooperation. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.136. PMID:. IF:13.300(Q1/1D).

Dababneh, SF, Claydon, TW, Shafaattalab, S, Prondzynski, M, Kashihara, H, Hove-Madsen, L, Sanatani, S. In Memoriam: Glen F. PhD. CANADIAN JOURNAL OF CARDIOLOGY. 2026; 42(5)DOI:10.1016/j.cjca.2026.03.002. PMID:41796860. IF:5.300(Q1/2D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahone, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis (vol 48, 502442. 2025). Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502639. PMID:41571546. IF:1.900(Q3/7D).

Younossi, ZM, Yu, ML, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Shenoy, KT, Mohan, L, Fan, JG, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Alqahtani, S, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, CA, D'Ambrosio, R, Lampertico, P, Al Naamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Papatheodoridi, M, Zoncape, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, AL, Lombardi, R, Aghemo, A, Zelber-Sagi, S, Lam, B, Racila, A, Stepanova, M. Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ampuero, J, Crespo, J, Maya-Miles, D, Ibañez-Samaniego, L, Panero, JLC, Graupera, I, Jiménez-Massip, A, Aller, R, Gómez-Camarero, J, Benlloch, S, Martin-Mateos, R, Morillas, RM, Gallego-Durán, R, Bernal, V, Turnes, J, Sanchez, MD, Poca, M, Martínez, RL, Escudero-García, D, Lo Iacono, O, Olveira, A, Francés, R, Iruzubieta, P, Lopez, LS, Esteban, JR, Soria, A, Pericàs, JM, Romero-Gómez, M. Clinical significance of patients with significant fibrosis missed by the EASL algorithm in metabolic-associated steatotic liver disease: findings from the HEPAMET registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Maya-Miles, D, Aller, R, Crespo, J, Ibañez-Samaniego, L, González, A, Pericàs, JM, Sanchez, MD, Escudero-Garcia, D, Rosales-Zábal, JM, Benlloch, S, Gómez-Camarero, J, Diez, R, Pavon-Castillero, E, Graupera, I, Latorre, R, Morillas, RM, Panero, JLC, Turnes, J, Aspichueta, P, Gallego-Durán, R, Francés, R, Martin-Mateos, R, Bernal, V, Poca, M, Olveira, A, Rodriguez, CF, Andrade, RJ, Carnicero, C, Iruzubieta, P, Lopez, LS, Fuertes-Yebra, E, Jiménez-Massip, A, Romero-Gómez, M, Ampuero, J. The body roundness index as a novel anthropometric marker in metabolic-associated steatotic liver disease: findings from the HEPAMET registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Bertot, LC, Roberts, S, Ampuero, J, Crespo, J, Iruzubieta, P, Maya-Miles, D, Carrillo-Fernández, P, Kemp, W, Mohamedashrafali, MAAC, Teoh, B, Ibañez-Samaniego, L, Lopez, LS, Sigüenza, R, Arroyo-López, V, Esteban, JR, Guerra, JA, Romero-Gómez, M, Camarero, JG, Albillos, A, Poca, M, Andrade, RJ, Ortiz, JPT, Sanchez, MD, George, J, Wallace, M, Aller, R, Adams, L. Optimizing hepatocellular cancer surveillance in metabolic dysfunction-associated steatotic liver disease based on liver stiffness measurement. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Lázaro, DR, Jiménez-Massip, A, El Maimouni, C, Canillas, L, Vergara, M, Poca, M, Rodríguez-Castellano, A, Munoz, EE, Serra, I, Pagès, L, Carrión, J, Soria, A, Mas, E, Morillas, RM, Ginès, P, Graupera, I, Broquetas, T, Pericàs, JM. Social determinants of health are associated with the risk of hepatic and cardiovascular events in patients with advanced MASLD: prediction using the novel LiverSocial score. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Healthcare provider perspectives on mental health in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: the role of multidisciplinary teams and sex differences. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Factors influencing mental health care provision for people with metabolic dysfunction-associated steatotic liver disease and steatohepatitis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease. Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502640. PMID:. IF:1.900(Q3/7D).

Diamantopoulos, L, Kalligeros, M, Isaacs, SD, Mauricio, D. Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity. Clinics in Liver Disease. 2026; 30(2)DOI:10.1016/j.cld.2025.12.001. PMID:42142893. IF:4.100(Q1/3D).

Milad, C, Mesa, A. The echo of a question, ten years later: Letter to Amanda and Jesus. Endocrinologia Diabetes y Nutricion. 2026; 73(5)DOI:10.1016/j.endien.2026.501772. PMID:41887969. IF:1.800(Q3/8D).

Hong, CZ, Ballester, MP, Perricone, G, Merli, M, Buti, M, Panero, JLC, Soriano, G, Toniutto, P, Ampuero, J, Russo, FP, Sacerdoti, D, Coenraad, M, Berenguer, M, Piano, S, Sangiovanni, A, Albillos, A, Gander, A, Patel, VC, Caraceni, P, Wright, G, Iruzubieta, P, Andrade, RJ, Garcia-Samaniego, FJ, Verhelst, X, Uson, E, Sanchez-Garrido, C, Mehta, G, Jalan, R. Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

El Maimouni, C, Jiménez-Massip, A, Canillas, L, Serra, I, Vergara, M, Morillas, RM, Poca, M, Broquetas, T, Rodríguez-Castellano, A, Munoz, EE, Soria, A, Pages, L, Carrión, J, Casas, M, Ardevol, A, Rojo, D, Alonso, N, Julián, MT, Bassegoda, O, Gines, P, Pericàs, JM, Graupera, I. Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Juanola, A, Moreta, MJ, Solé, C, Perez-Guasch, M, Gratacós-Ginès, J, Soria, A, Cuyàs, B, Martin-Llahi, M, Ma, A, Pompili, E, Fernández, I, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Ginès, P. Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Biswas, S, Aggarwal, A, Lo, GH, Luo, XF, Yang, L, Escorsell, A, Mehta, S, Swaroop, S, Agarwal, S, Agarwal, A, Mishra, A, Tripathi, S, Gunjan, D, Gamangatti, S, Shalimar. Efficacy and safety of endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: systematic review and individual patient data meta-analysis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Canillas, L, Jimenez-Esquivel, N, Amador, A, Brujats, A, Sánchez, J, Pelegrina, A, Pardo, C, Montaña, SH, Fajol, MC, de Sárraga, C, Alvarez, J, Duran, X, Burdio, F, Reverter, E, Carrión, JA. Predictive model of postoperative mortality in patients with cirrhosis. Surgical risk score for patients with cirrhosis (S-RISC). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Salomone, F, Gil-Gómez, A, Barreca, F, Longo, M, Soriano, G, Francés, R, Gallego-Durán, R, Herrojo, JA, Tafani, M, Dongiovanni, P, Romero-Gómez, M. SIRT5 rs12216101 T > G variant is associated with hepatic encephalopathy and impaired ammonia metabolism in patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Fernández-Aguilera, M, Calvo-Orteu, M, Aparicio, AP, Carrión, JA, de Miera, IS, Vergara, M, Poca, M, Canga, E, Ardevol, A, Ariza, X, Amador, A, Sáez-Peñataro, J, Forns, X, Barciela, MR. Rechallenge after a DILI episode: importance of the pattern and the medication class. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).